Related topics: cancer , hepatitis c , liver , hepatitis b
Liver cancer
hideLiver cancer is a cancer that starts in the liver. For a thorough understanding of liver cancer it is important to know a brief summary of how the liver works and functions. The liver is the largest organ in the body. It is located below the right lung and under the ribcage. The liver is divided into two lobes: the right lobe and left lobe. Protein is obtained by the liver from a set of sources. The portal vein carries nutrient rich blood from the intestines to the liver and the hepatic artery supplies the liver with blood that is rich in oxygen. Multiple types of tumors can develop in the liver because the liver is made up of many various cells. Tumors that are cancerous are termed malignant and tumors that do not contain cancer are termed benign. Liver cancer is characterized by the presence of malignant hepatic tumors -- tumors or growths on or in the liver (medical terms pertaining to the liver often start in hepato- or hepatic from the Greek word for liver, hēpar, stem hēpat-). They may be discovered on medical imaging (even for a different reason than the cancer itself), or may be present in patients as an abdominal mass, abdominal pain, jaundice, or some other liver dysfunction.
For more information about Liver cancer, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with liver cancer
Scientists Uncover Protective Mechanism Against Liver Cancer
Dec 14, 2009 |
4 / 5 (1) |
0
(PhysOrg.com) -- A team of scientists from the UC San Diego School of Medicine and Osaka University in Japan have identified a protein switch that helps prevent liver damage, including inflammation, fibrosis and cancer. The ...
First live targeting of tumors with RNA-based technology
Nov 30, 2009 |
4 / 5 (1) |
0
(PhysOrg.com) -- Finding and treating a tumor without disturbing normal tissue presents challenges - sometimes the most effective therapies can be invasive and harsh.
New suppressor of common liver cancer
Dec 15, 2009 |
not rated yet |
0
Tumor suppressor genes make proteins that help control cell growth. Mutations in these genes that generate nonfunctional proteins can contribute to tumor development and progression. One of the most well-known tumor suppressor ...
New data show breakthrough microRNA-targeted therapy holds promise as new treatment for hepatitis C
Dec 03, 2009 |
5 / 5 (1) |
0
A study published online in this week's Science shows that SPC3649, a breakthrough microRNA-targeted therapy developed by Santaris Pharma A/S, holds promise as a novel treatment for patients infected with the Hepatitis C viru ...
Search results for liver cancer
Smoking and Drinking Linked to Bowel Cancer: Know Your Risks
Dec 17, 2009 |
not rated yet |
0
(PhysOrg.com) -- Besides delectable dishes that help us pack on the pounds during the holiday season, many people also let loose with a bottle of wine or a pack of cigarettes. Richard Rood, MD, says moderation ...
Cigarette smoking increases colorectal cancer risk
Dec 04, 2009 |
not rated yet |
0
New study results strengthen the evidence that people who smoke cigarettes over a long period of time have an increased risk for developing colorectal cancer, even after adjusting for other risk factors.
CT imaging taken post avastin may predict survival in patients with metastatic colorectal cancer
Dec 01, 2009 |
not rated yet |
0
Using routine computed tomography (CT) imaging to analyze form and structural changes to colorectal liver metastasis after bevacizumab and chemotherapy may predict overall survival, according to research from The University ...
Experts: Colon cancer deaths could make big drop
Dec 07, 2009 |
5 / 5 (1) |
0
(AP) -- Colon cancer deaths could drop dramatically in the next decade because of better screening and treatment, according to an optimistic new prediction by top researchers.
Defibrotide improves response rate in patients with severe veno-occlusive disease of the liver
Dec 08, 2009 |
not rated yet |
0
Defibrotide, a novel drug which modulates the response of blood vessels to injury, was markedly more effective than standard treatment in post-stem cell transplant patients with hepatic veno-occlusive disease, a life threatening ...
Clinical trial advances new approach to re-sensitizing breast cancer
Dec 13, 2009 |
not rated yet |
0
A new drug cocktail might be the right mix to fight breast cancer after it becomes resistant to standard therapy. Details of a new study supporting this approach suggest it's possible to re-sensitize tumors thus allowing ...
Gefitinib improves survival compared with standard chemotherapy in lung cancer patients with genetic mutation
Dec 20, 2009 |
5 / 5 (1) |
0
Patients with the most common form of lung cancer (non-small-cell lung cancer) who have mutations in the epidermal growth factor receptor (EGFR) gene have significantly improved progression-free survival if they are treated ...
Heavy drinkers exercise to burn off alcohol: British study
Nov 26, 2009 |
not rated yet |
0
More than a quarter of drinkers in England who exercise regularly do so in an attempt to make up for bingeing on alcohol, according to a survey published Thursday.
Decline of hormone therapy decreases breast cancer cases, analysis finds
Dec 09, 2009 |
2.5 / 5 (4) |
0
The declining use of hormone therapy among women has led to 6,000 fewer invasive breast cancer cases a year, according to an analysis by researchers at the University of Wisconsin-Madison. The research quantifies and advances ...
Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD
Dec 04, 2009 |
5 / 5 (1) |
0
Cholesterol-lowering drugs known as statins are among the most prescribed medicines in the U.S. Now a new study by researchers at Fred Hutchinson Cancer Research Center indicates that statins may protect stem cell transplant ...
List of search results for liver cancer
